Home
>
US Stocks
>
Vericel Corp
Vericel Corp
VCEL

Vericel Corp (VCEL)

$50.753.57%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$50.95
Today Low/High$50.3 / $51
52 Week Low/High$14.84 / $68.94
P/E ratio265.06
Market Cap$2.32B

Company Details

Vericel is a leader in advanced therapies for the sports medicine and severe burn care markets. The company markets two cell therapy products in the United States. MACI® (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. The company also holds an exclusive license for North American rights to NexoBrid®, a registration-stage biological orphan product for debridement of severe thermal burns.
OrganisationVericel Corp
HeadquatersCambridge, Massachusetts, US
Employees273
IndustryHealth Technology
CEODominick Colangelo

Discover more

Frequently Asked Questions

What is Vericel Corp (VCEL) share price today?

Can Indians buy Vericel Corp (VCEL) shares?

How can I buy Vericel Corp (VCEL) shares from India?

Can Fractional shares of Vericel Corp (VCEL) be purchased?

What are the documents required to start investing in Vericel Corp (VCEL) stocks?

We are a SEBI registered investement advisor